🔎 Trials Near Me

Home › Quitting Smoking › NCT07419425

My Path to Quit Tobacco

RecruitingPhase 4Healthy volunteers welcome

Comparing Three Multicomponent Interventions to Help Adults Quit Smoking

Who can join

Ages 21 and older · All sexes · Healthy volunteers welcome

Full eligibility criteria
Inclusion Criteria:

* self-identify as Black
* smoke cigarettes (greater than or equal to 1 cigarette on greater than or equal to 4 days/week)
* motivated to quit smoking
* willing to discontinue any non-study smoking cessation pharmacotherapy use during study treatment.

Exclusion Criteria:

* currently taking bupropion for non-smoking cessation reasons

About the study

The overarching goal of this program of research is to reduce smoking-related health disparities by increasing smoking cessation among Black adults. The goal of this research proposal is to determine whether more intensive, culturally specific, evidence-based interventions are more effective at promoting long-term cessation and other key patient-centered outcomes compared to the usual evidence-based standard of care: services provided by a state-run quitline. This study compares the relative effectiveness of three different treatments (Standard, Intensive, and Intensive Incentivized) on long-term smoking cessation (biochemically confirmed abstinence from combusted tobacco at 26-weeks post-target quit day) among Black adults who smoke and want to quit.

What is being tested

Sponsor: University of Wisconsin, Madison · Participants: 1,550 · Started: Jul 6, 2026

Contact the study team

Official record on ClinicalTrials.gov — NCT07419425

Locations in the U.S.

ArizonaArizona State University, Phoenix (Not yet recruiting)
IndianaIndiana University, Indianapolis (Not yet recruiting)
KansasUniversity of Kansas Medical Center Research Institute, Inc, Kansas City (Not yet recruiting)
VirginiaVirginia Commonwealth University, Richmond (Not yet recruiting)
WisconsinUW School of Medicine and Public Health, Milwaukee

Conditions

From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.